Az antithromboticus kezelés újdonságai a kardiológiában

Translated title of the contribution: What is new in antithrombotic therapy in cardiology

Research output: Contribution to journalArticle

Abstract

Substantial development has been made in the field of antithrombotic therapy of heart diseases during the last two years. The "gold constant" combination of heparin, coumadin, aspirin and clopidogrel has been started to be questioned. All of the traditional drugs have or will have new classmates in the near future. New drugs have become available with new targets, new way of action with theoretical as well as practical advantages.

Original languageHungarian
Pages (from-to)2016-2020
Number of pages5
JournalOrvosi Hetilap
Volume153
Issue number51
DOIs
Publication statusPublished - Dec 1 2012

Fingerprint

clopidogrel
Cardiology
Warfarin
Gold
Pharmaceutical Preparations
Aspirin
Heparin
Heart Diseases
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Az antithromboticus kezelés újdonságai a kardiológiában. / Kiss, R.

In: Orvosi Hetilap, Vol. 153, No. 51, 01.12.2012, p. 2016-2020.

Research output: Contribution to journalArticle

@article{ce326603f0fa4a2ea7a3a5add94adf22,
title = "Az antithromboticus kezel{\'e}s {\'u}jdons{\'a}gai a kardiol{\'o}gi{\'a}ban",
abstract = "Substantial development has been made in the field of antithrombotic therapy of heart diseases during the last two years. The {"}gold constant{"} combination of heparin, coumadin, aspirin and clopidogrel has been started to be questioned. All of the traditional drugs have or will have new classmates in the near future. New drugs have become available with new targets, new way of action with theoretical as well as practical advantages.",
keywords = "antiplatelets, antithrombotic treatment, atrial fi brillation, myocardial infarction, stroke",
author = "R. Kiss",
year = "2012",
month = "12",
day = "1",
doi = "10.1556/OH.2012.29505",
language = "Hungarian",
volume = "153",
pages = "2016--2020",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "51",

}

TY - JOUR

T1 - Az antithromboticus kezelés újdonságai a kardiológiában

AU - Kiss, R.

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Substantial development has been made in the field of antithrombotic therapy of heart diseases during the last two years. The "gold constant" combination of heparin, coumadin, aspirin and clopidogrel has been started to be questioned. All of the traditional drugs have or will have new classmates in the near future. New drugs have become available with new targets, new way of action with theoretical as well as practical advantages.

AB - Substantial development has been made in the field of antithrombotic therapy of heart diseases during the last two years. The "gold constant" combination of heparin, coumadin, aspirin and clopidogrel has been started to be questioned. All of the traditional drugs have or will have new classmates in the near future. New drugs have become available with new targets, new way of action with theoretical as well as practical advantages.

KW - antiplatelets

KW - antithrombotic treatment

KW - atrial fi brillation

KW - myocardial infarction

KW - stroke

UR - http://www.scopus.com/inward/record.url?scp=84871402259&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871402259&partnerID=8YFLogxK

U2 - 10.1556/OH.2012.29505

DO - 10.1556/OH.2012.29505

M3 - Article

C2 - 23248056

AN - SCOPUS:84871402259

VL - 153

SP - 2016

EP - 2020

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 51

ER -